Search

everythinglearnresearchcommunity

for

Search:↓

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Upadacitinib may cause hair loss.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

New grading scale accurately measures hair loss severity and treatment effectiveness.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

More severe alopecia areata can lower quality of life.

1.5% lactic acid improved mink growth and health best.

AVT is highly conserved and may have antimicrobial properties.

JAK inhibitors show promise for treating various skin diseases.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

Patients with alopecia areata in the UK face barriers to care, needing better-defined pathways and more education for general practitioners.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.

Gagamchengyoung-tang may help improve hair growth and scalp health in certain alopecia patients.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Good communication helps predict successful aging in older Indonesians.

Tattoos may trigger autoimmune symptoms in some people.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

The Egyptian Arabic Skindex-16 is a reliable way to measure how skin diseases affect quality of life in Egyptian patients.